ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease
Value in Health
◽
10.1016/j.jval.2016.09.1180
◽
2016
◽
Vol 19
(7)
◽
pp. A550
Author(s):
R Yagudina
◽
A Kulikov
◽
E Makarova
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
◽
Aclidinium Bromide
Download Full-text
Related Documents
Cited By
References
Cost-effectiveness and budget impact analysis of smoking cessation interventions in chronic obstructive pulmonary disease patients in Thailand
Tobacco Induced Diseases
◽
10.18332/tid/83780
◽
2018
◽
Vol 16
(1)
◽
Author(s):
Ronnachai Kongsakon
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Smoking Cessation
◽
Cost Effectiveness
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
PRS17 - BUDGET IMPACT ANALYSIS OF THE USE OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
Value in Health
◽
10.1016/j.jval.2018.09.2411
◽
2018
◽
Vol 21
◽
pp. S406
Author(s):
L.A. Vallejo-Aparicio
◽
A. Huerta
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
BUDGET IMPACT ANALYSIS OF HOME ADVANCED NON-INVASIVE VENTILATION FOR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Value in Health
◽
10.1016/j.jval.2016.03.690
◽
2016
◽
Vol 19
(3)
◽
pp. A299
Author(s):
S. Coughlin
◽
F.W. Peyerl
◽
S.H. Munson
◽
A.J. Ravindranath
◽
Jr. T.L. Lee-Chiong
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Invasive Ventilation
◽
Obstructive Pulmonary Disease
◽
Non Invasive
◽
Non Invasive Ventilation
Download Full-text
Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia
Value in Health
◽
10.1016/j.jval.2017.08.2662
◽
2017
◽
Vol 20
(9)
◽
pp. A888
Author(s):
A Patino
◽
E Karpf
◽
D Londoño
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in Colombia
Value in Health
◽
10.1016/j.jval.2012.03.297
◽
2012
◽
Vol 15
(4)
◽
pp. A53
Author(s):
L.F. Giraldo
◽
J.G. Ariza
◽
T. Acosta
◽
J.F. Pinzon
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian Federation
Value in Health
◽
10.1016/j.jval.2012.03.296
◽
2012
◽
Vol 15
(4)
◽
pp. A53
Author(s):
A. Kulikov
◽
I. Komarov
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Russian Federation
◽
Standard Therapy
◽
Ipratropium Bromide
◽
Impact Analysis
◽
Budget Impact
◽
Tiotropium Bromide
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
PRS1 BUDGET IMPACT ANALYSIS OF UMECLIDINIUM VERSUS TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
Value in Health Regional Issues
◽
10.1016/j.vhri.2019.08.424
◽
2019
◽
Vol 19
◽
pp. S77
Author(s):
D. Silva
◽
L.T.M. Saturnino
◽
M.R. Gazzotti
◽
O.A. Nascimento
◽
R. Alfonso-Cristancho
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Healthcare System
◽
Impact Analysis
◽
Budget Impact
◽
Public Healthcare
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
◽
System Perspective
◽
Healthcare System Perspective
Download Full-text
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective
Value in Health
◽
10.1016/j.jval.2011.08.1402
◽
2011
◽
Vol 14
(7)
◽
pp. A489-A490
Author(s):
C. Suzuki
◽
N.L. Silva
Keyword(s):
Public Health
◽
Chronic Obstructive Pulmonary Disease
◽
Health Care
◽
Pulmonary Disease
◽
Health Care System
◽
Budget Impact
◽
Public Health Care
◽
Chronic Obstructive
◽
Public Health Care System
◽
Obstructive Pulmonary Disease
Download Full-text
Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice
Value in Health
◽
10.1016/j.jval.2019.05.006
◽
2019
◽
Vol 22
(10)
◽
pp. 1092-1101
◽
Cited By ~ 4
Author(s):
Tanja Fens
◽
Simon van der Pol
◽
Janwillem W.H. Kocks
◽
Maarten J. Postma
◽
Job F.M. van Boven
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Economic Impact
◽
Pulmonary Disease
◽
Budget Impact
◽
Inhaled Corticosteroids
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
Download Full-text
Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)
Cochrane Database of Systematic Reviews
◽
10.1002/14651858.cd011594.pub2
◽
2018
◽
Cited By ~ 3
Author(s):
Han Ni
◽
Soe Moe
◽
Zay Soe
◽
Kay Thi Myint
◽
K Neelakantan Viswanathan
Keyword(s):
Chronic Obstructive Pulmonary Disease
◽
Pulmonary Disease
◽
Chronic Obstructive
◽
Obstructive Pulmonary Disease
◽
Aclidinium Bromide
◽
Long Acting
◽
Beta2 Agonist
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close